Sellas Life Sciences Group Inc (NASDAQ:SLS)

5.58
Delayed Data
As of May 18
 +0.04 / +0.72%
Today’s Change
3.43
Today|||52-Week Range
19.41
-32.63%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$36.9M

Company Description

Develop biopharmaceuticals

Contact Information

SELLAS Life Sciences Group, Inc.
315 Madison Avenue
New York New York 10017
P:(917) 438-4353
Investor Relations:

Employees

Shareholders

Other institutional7.13%
Individual stakeholders7.10%
Mutual fund holders2.00%

Top Executives

Angelos M. StergiouPresident, Chief Executive Officer & Director
Gene C. MackChief Financial Officer & Treasurer
Nicholas J. SarlisDirector, Chief Medical Officer & Senior VP
Barbara A. WoodSecretary, Executive VP & General Counsel
John T. BurnsCorporate Controller & VP-Finance